Ad is loading...
JVMAX
Price
$29.71
Change
-$0.23 (-0.77%)
Updated
Nov 15 closing price
MCVAX
Price
$11.83
Change
-$0.08 (-0.67%)
Updated
Nov 15 closing price
Ad is loading...

JVMAX vs MCVAX

Header iconJVMAX vs MCVAX Comparison
Open Charts JVMAX vs MCVAXBanner chart's image
JHancock Disciplined Value Mid Cap A
Price$29.71
Change-$0.23 (-0.77%)
VolumeN/A
CapitalizationN/A
Transamerica Mid Cap Value Opps A
Price$11.83
Change-$0.08 (-0.67%)
VolumeN/A
CapitalizationN/A
JVMAX vs MCVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVMAX vs. MCVAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMAX is a Buy and MCVAX is a Buy.

FUNDAMENTALS
Fundamentals
JVMAX has more cash in the bank: 23.8B vs. MCVAX (1.23B). JVMAX pays higher dividends than MCVAX: JVMAX (0.67) vs MCVAX (0.52). JVMAX was incepted earlier than MCVAX: JVMAX (27 years) vs MCVAX (11 years). MCVAX is a more actively managed with annual turnover of: 44.00 vs. JVMAX (41.00). JVMAX (1000) and MCVAX (1000) have matching initial minimum investment requirements. JVMAX annual gain was more profitable for investors over the last year : 21.07 vs. MCVAX (12.67). JVMAX return over 5 years is better than : 42.69 vs. MCVAX (1.29).
JVMAXMCVAXJVMAX / MCVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years11 years-
Gain YTD14.3139.032158%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets23.8B1.23B1,941%
Annual Yield % from dividends0.670.52128%
Returns for 1 year21.0712.67166%
Returns for 3 years6.26-21.35-29%
Returns for 5 years42.691.293,307%
Returns for 10 years56.9712.86443%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HKD2.74-0.09
-3.18%
AMTD Digital
SPB88.22-5.64
-6.01%
Spectrum Brands Holdings
IPG27.09-2.11
-7.23%
Interpublic Group of Companies (The)
SBFM2.35-0.23
-8.75%
Sunshine Biopharma Inc
IKT2.05-0.31
-13.14%
Inhibikase Therapeutics